Sachse G, Willms B
Med Klin. 1979 Nov 2;74(44):1635-40.
Serum insulin was measured after maximal stimulation in 213 patients with apparent secondary failure of treatment with sulfonylureas. The maximal increase of serum insulin was 327% of baseline in patients treated with oral drugs alone and 175% in patients switched to insulin. The control of diabetes in the patients treated with oral drugs alone was investigated 2 to 3 years later by a questionnaire and correlated to the insulin values measured earlier. Following conclusions were drawn: Sulfonylurea treatment is indicated if the increase of serum insulin is more than 300%. If the increase of serum insulin is below 200%, insulin treatment is necessary now or in the near future. The determination of serum insulin after maximal stimulation in patients with apparent secondary failure of sulfonylurea treatment has a diagnostic as well as a prognostic value.
对213例明显存在磺脲类药物继发性治疗失败的患者进行最大刺激后测定血清胰岛素。仅接受口服药物治疗的患者血清胰岛素最大增幅为基线的327%,改用胰岛素治疗的患者为175%。2至3年后通过问卷调查对仅接受口服药物治疗患者的糖尿病控制情况进行了调查,并将其与早期测得的胰岛素值进行关联。得出以下结论:如果血清胰岛素增幅超过300%,则表明适合采用磺脲类药物治疗。如果血清胰岛素增幅低于200%,则现在或不久后有必要进行胰岛素治疗。对明显存在磺脲类药物继发性治疗失败的患者进行最大刺激后测定血清胰岛素具有诊断和预后价值。